TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35856046

Group type: EXPERIMENTAL
Intervention: INSTR (therapeutic exercise program with instructions)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (therapeutic exercise program without instructions)
Number of subjects: 20
Study: 32112550

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea syndrome (OSAS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct observational case-control study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea syndrome (OSAS) in Asian population
Number of subjects: 0
Study: 35972345

Group type: EXPERIMENTAL
Intervention: CIRAS model based on ascites discomfort score, plasma sodium levels, and diuretic treatment.
Number of subjects: 1162

Group type: COMPARATOR
Intervention: Standard ascites classification (refractory vs. diuretic-responsive)
Number of subjects: 1162

Group type: EXPERIMENTAL
Intervention: Child-Pugh score, MELD, MELD-Na, MELD 3.0
Number of subjects: 1162
Study: 36440779

Group type: EXPERIMENTAL
Intervention: Prospekta, 1 tablet twice daily
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Prospekta
Number of subjects: 363
Study: 34071714

Group type: EXPERIMENTAL
Intervention: n-3 PUFA-enriched hen eggs (1053 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Regular hen eggs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: n-3 PUFA-enriched hen eggs
Number of subjects: 40
Study: 35967319

Group type: EXPERIMENTAL
Intervention: aGAPSS-IS nomogram
Number of subjects: 478

Group type: COMPARATOR
Intervention: aGAPSS
Number of subjects: 478
Study: 32191150

Group type: EXPERIMENTAL
Intervention: Perfluorocarbon liquids
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no perfluorocarbon liquids)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: A group (multiple layers)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: B group (single layer)
Number of subjects: 55
Study: 34743118

Group type: EXPERIMENTAL
Intervention: VYC-20L (20 mg/mL hyaluronic acid gel with lidocaine) administered via cannula
Number of subjects: 60

Group type: COMPARATOR
Intervention: Needle injection of VYC-20L
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: VYC-20L via cannula
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Injection-site responses (ISRs)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Procedural pain
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 60
Study: 36432601

Group type: EXPERIMENTAL
Intervention: Consumption of IX-containing fruits (yellow cactus pear)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (white cactus pear)
Number of subjects: 0
Study: 34864943

Group type: EXPERIMENTAL
Intervention: Maribavir 400mg BID
Number of subjects: 352

Group type: COMPARATOR
Intervention: Investigator-assigned therapy (IAT)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Maribavir
Number of subjects: 352
Study: 36178200

Group type: EXPERIMENTAL
Intervention: Laryngeal mask anesthesia (LMA)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Endotracheal intubation (ETT)
Number of subjects: 107
Study: 34139320

Group type: EXPERIMENTAL
Intervention: Percutaneous ablation
Number of subjects: 272

Group type: COMPARATOR
Intervention: Control (sorafenib or TARE)
Number of subjects: 272
Study: 616026142

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) therapy, 3 sessions over 45 days
Number of subjects: 28
Study: 34652564

Group type: EXPERIMENTAL
Intervention: Viloxazine ER sprinkled on applesauce
Number of subjects: 25

Group type: COMPARATOR
Intervention: Viloxazine ER intact capsule after a 10-h fast (control condition)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Viloxazine ER intact capsule with a standard high-fat meal
Number of subjects: 25
Study: 32172295

Group type: COMPARATOR
Intervention: Non-medicated ADHD children
Number of subjects: 63

Group type: COMPARATOR
Intervention: Medicated ADHD children
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Visual stimulus
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Variability of accommodation
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Time-on-task
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Group differences in accommodation variability
Number of subjects: 63
Study: 35727277

Group type: EXPERIMENTAL
Intervention: MRI-guided fibrosis ablation plus pulmonary vein isolation (PVI)
Number of subjects: 843

Group type: COMPARATOR
Intervention: PVI alone
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: MRI-guided fibrosis ablation plus PVI
Number of subjects: 843
Study: 32985190

Group type: EXPERIMENTAL
Intervention: Guest removal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Application of external physical pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Solvated species (1Cl·2H2O and 2Br·2H2O)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chloro- and bromo-functionalized ligands
Number of subjects: 0
Study: 35818280

Group type: EXPERIMENTAL
Intervention: Hydrofluoric Acid 9% + Silane + Orthodontic adhesive (Transbond™ XT Light Cure Adhesive Primer, 3M ESPE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hydrofluoric Acid 9% + Universal adhesive (UA) (Scotchbond Universal®, 3M ESPE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Universal adhesive (UA) only
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Monobond Etch & Prime® (Ivoclar) + UA
Number of subjects: 40
Study: 33507809

Group type: EXPERIMENTAL
Intervention: IMRT + C (60 Gy of intensity-modulated radiation therapy over 6 weeks with concurrent weekly cisplatin)
Number of subjects: 306

Group type: COMPARATOR
Intervention: IMRT (60 Gy intensity-modulated radiation therapy over 5 weeks)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: IMRT + C
Number of subjects: 306

Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 306
Study: 32227643

Group type: EXPERIMENTAL
Intervention: Vilaprisan 2 mg (single oral dose)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (normal renal function)
Number of subjects: 9
Study: 34388288

Group type: EXPERIMENTAL
Intervention: ADAPT program
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 282
Study: 33511505

Group type: EXPERIMENTAL
Intervention: Multiplayer, immersive, interactive virtual reality application (VR group)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Physical equipment (TP group)
Number of subjects: 289
Study: 32942085

Group type: EXPERIMENTAL
Intervention: AMO-02 (tideglusib) 400 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: AMO-02 (tideglusib) 1000 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: AMO-02 (tideglusib)
Number of subjects: 16
Study: 35061058

Group type: EXPERIMENTAL
Intervention: CEUS-guided PCNL
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional US-guided PCNL
Number of subjects: 72
Study: 33470741

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Number of subjects: 12
Study: 35904646

Group type: EXPERIMENTAL
Intervention: Couples Employment Program (CEP), an eight-session program integrating job search strategies and couple communication sessions.
Number of subjects: 1477

Group type: EXPERIMENTAL
Intervention: Couples Employment Program (CEP)
Number of subjects: 1477
Study: 32770616

Group type: EXPERIMENTAL
Intervention: Planned Caesarean Section (CS)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Vaginal Delivery (VD)
Number of subjects: 434
Study: 32012977

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) over the left primary motor cortex for five days, combined with patient-controlled intravenous morphine analgesia (PCA-IV).
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sham tDCS stimulation, combined with patient-controlled intravenous morphine analgesia (PCA-IV).
Number of subjects: 55
Study: 35091049

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided 1 (USG1 - BCS 1-5/9)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided 2 (USG2 - BCS 6-9/9)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Palpation-guided 1 (PG1 - BCS 1-5/9)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Palpation-guided 2 (PG2 - BCS 6-9/9)
Number of subjects: 72
Study: 34129958

Group type: EXPERIMENTAL
Intervention: Stochastic finite element model for bone-implant interface stiffness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gap closure and subsequent stiffening
Number of subjects: 0
Study: 32336177

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with curcumin 0.75 mg/mL and blue LED (67 mW/cm2, 20.1 J/cm2)
Number of subjects: 0
Study: 32529929

Group type: EXPERIMENTAL
Intervention: Storytelling video about recovery following a suicide attempt
Number of subjects: 218

Group type: COMPARATOR
Intervention: Psychoeducational video about suicide
Number of subjects: 218
Study: 35273944

Group type: EXPERIMENTAL
Intervention: Ada
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Rheport
Number of subjects: 600

Group type: COMPARATOR
Intervention: Online search engines
Number of subjects: 600
Study: 32252783

Group type: EXPERIMENTAL
Intervention: Air Next spirometer
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional desktop spirometer
Number of subjects: 200
Study: 32918272

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 8–10 mg/kg of body weight
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 32730930

Group type: EXPERIMENTAL
Intervention: ABGS (250 μg rhBMP6/mL ABC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 32
Study: 36414208

Group type: EXPERIMENTAL
Intervention: Participant-initiated, ad hoc navigation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study-directed proactive navigation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 34338413

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 36109206

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 80

Group type: COMPARATOR
Intervention: Video‐assisted paravertebral block (PVB)
Number of subjects: 80
Study: 32567103

Group type: EXPERIMENTAL
Intervention: Telephone-guided imagery rehearsal therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 70
Study: 32046793

Group type: EXPERIMENTAL
Intervention: Higher-GI trifle (sucrose; GI 65)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Lower-GI trifle (isomaltulose; GI 34)
Number of subjects: 65
Study: 32171937

Group type: EXPERIMENTAL
Intervention: Standard rehabilitation plus movement training (MOVE)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard rehabilitation without movement training (CONTROL)
Number of subjects: 150
Study: 35090838

Group type: EXPERIMENTAL
Intervention: Inventory of Anal Sex Knowledge (iASK) measure
Number of subjects: 154

Group type: COMPARATOR
Intervention: HIV Knowledge Questionnaire (HIV-KQ-18)
Number of subjects: 154

Group type: COMPARATOR
Intervention: STD-Knowledge Questionnaire (STD-KQ)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Patient Health Questionnaire (PHQ-2)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Generalized Anxiety Disorder scale (GAD-2)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Employment status
Number of subjects: 154
Study: 33964140

Group type: EXPERIMENTAL
Intervention: High plasma HDL cholesterol concentrations (extreme high levels)
Number of subjects: 111984

Group type: COMPARATOR
Intervention: Genetically elevated HDL cholesterol
Number of subjects: 111984
Study: 33274867

Group type: EXPERIMENTAL
Intervention: Poultry manure (8 t ha-1) + Gigaspora gigantea inoculation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Poultry manure (12 t ha-1) + Glomus clarum inoculation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sole applications of poultry manure and AMF inoculums
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (un-inoculated)
Number of subjects: 20
Study: 35946167

Group type: EXPERIMENTAL
Intervention: DIALOG+
Number of subjects: 468

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 468
Study: 32623628

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) for 60 seconds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 0
Study: 34273647

Group type: EXPERIMENTAL
Intervention: Wheat (AME and AMEn)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sorghum (AME and AMEn)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Barley (AME and AMEn)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Corn (AME and AMEn)
Number of subjects: 6
Study: 32686050

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 45
Study: 35877164

Group type: EXPERIMENTAL
Intervention: Sleep Prompt App (SPA)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 116
Study: 33818134

Group type: EXPERIMENTAL
Intervention: Continuous Pokémon Go
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intermittent Pokémon Go
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional walking
Number of subjects: 20
Study: 33194976

Group type: EXPERIMENTAL
Intervention: Inspirational lecture
Number of subjects: 0
Study: 35162507

Group type: EXPERIMENTAL
Intervention: 12-week aerobic and resistance exercise group (EG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (EG and CG)
Number of subjects: 30
Study: 33462450

Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg kg‐1 every 2 weeks)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 199

Group type: COMPARATOR
Intervention: Maintenance chemotherapy
Number of subjects: 199
Study: 33007918

Group type: EXPERIMENTAL
Intervention: Starting Intervention (SI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups together
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waiting List Control (WL)
Number of subjects: 30
Study: 34238838

Group type: EXPERIMENTAL
Intervention: Deep sedation (MOAA/S 0 to 1)
Number of subjects: 431
Study: 32706852

Group type: EXPERIMENTAL
Intervention: FAMS (Family-focused Add-on to Motivate Self-care)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individualized text messaging intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (control)
Number of subjects: 0
Study: 32497217

Group type: EXPERIMENTAL
Intervention: Proximal glucose infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Distal glucose infusion
Number of subjects: 20
Study: 33432387

Group type: EXPERIMENTAL
Intervention: 3D imaging
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non-3D imaging
Number of subjects: 44
Study: 36397362

Group type: EXPERIMENTAL
Intervention: Head acupuncture combined with modern rehabilitation training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Body acupuncture combined with modern rehabilitation training
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups (Head and Body acupuncture)
Number of subjects: 90
Study: 33024271

Group type: EXPERIMENTAL
Intervention: lenvatinib-plus-everolimus
Number of subjects: 40
Study: 34171822

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg b.i.d. for eight weeks
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 34082190

Group type: EXPERIMENTAL
Intervention: Foam Roller (FR)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Vibration Foam Roller (VFR)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Passive Recovery (PR)
Number of subjects: 7
Study: 32769647

Group type: EXPERIMENTAL
Intervention: Midurethral sling and behavioral and pelvic floor muscle therapy (combined group)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Midurethral sling alone
Number of subjects: 403
Study: 34375164

Group type: EXPERIMENTAL
Intervention: Uncovered metallic stent (uncovered MS)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Covered metallic stent (covered MS)
Number of subjects: 92
Study: 32041588

Group type: EXPERIMENTAL
Intervention: MI self-coding exercise using smartphone recording and a standardized scoring sheet
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control condition (watching an MI expert perform in a video clip)
Number of subjects: 55
Study: 34261911

Group type: EXPERIMENTAL
Intervention: Spleen aminopeptide oral lyophilized powder (SAOLP) 4 mg qd for two cycles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spleen aminopeptide oral lyophilized powder (SAOLP)
Number of subjects: 0
Study: 32145280

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) 3 times a week for 8 weeks, with work periods of 4 × 4 minutes at 85%-95% of peak heart rate and 3 minutes of active recovery at 50%-70% of peak heart rate.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard care according to national guidelines.
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 70
Study: 33507574

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg) administered 24 to 35 weeks after the last denosumab dose
Number of subjects: 53
Study: 34565343

Group type: EXPERIMENTAL
Intervention: Robot-assisted minimally invasive esophagectomy (RAMIE)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Minimally invasive esophagectomy (MIE)
Number of subjects: 218
Study: 35899459

Group type: EXPERIMENTAL
Intervention: GOLDIC therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Epidural steroid injections (dexamethasone)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Manual therapy
Number of subjects: 90
Study: 33762032

Group type: EXPERIMENTAL
Intervention: Early childhood mental health consultation (ECMHC)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Waitlist-control
Number of subjects: 190
Study: 34479593

Group type: COMPARATOR
Intervention: Intravenous Tranexamic Acid (1g TXA IV)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Peri-articular Injection of Tranexamic Acid (1g TXA injected peri-articularly)
Number of subjects: 93
Study: 33225963

Group type: COMPARATOR
Intervention: Naltrexone (active control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Varenicline (promising AUD pharmacotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36227836

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left inferior primary motor cortex for 15 minutes
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sham group received 30s of stimulation
Number of subjects: 9
Study: 33932503

Group type: EXPERIMENTAL
Intervention: Adjuvant T-DM1
Number of subjects: 743

Group type: COMPARATOR
Intervention: Trastuzumab
Number of subjects: 743
Study: 32872401

Group type: EXPERIMENTAL
Intervention: HE‐HFD (+50% energy, 65% fat)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control diet (36% fat)
Number of subjects: 12
Study: 36068705

Group type: EXPERIMENTAL
Intervention: IV sulopenem followed by oral sulopenem etzadroxil/probenecid
Number of subjects: 1392

Group type: COMPARATOR
Intervention: IV ertapenem followed by oral ciprofloxacin or amoxicillin-clavulanate
Number of subjects: 1392
Study: 34866483

Group type: EXPERIMENTAL
Intervention: Behavioral lifestyle intervention for T2DM prevention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard of care (wait-listed control)
Number of subjects: 42
Study: 35340107

Group type: EXPERIMENTAL
Intervention: Dyston® (40–60 units)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Dysport® (40–60 units)
Number of subjects: 126
Study: 33734910

Group type: EXPERIMENTAL
Intervention: Preservative-Free (PF) brimonidine/timolol fixed-combination (BTFC) ophthalmic solution
Number of subjects: 106

Group type: COMPARATOR
Intervention: Preservative-Containing (PC) brimonidine/timolol fixed-combination (BTFC) ophthalmic solution
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both PF and PC groups
Number of subjects: 106
Study: 33109670

Group type: EXPERIMENTAL
Intervention: e‐TIS app
Number of subjects: 2806

Group type: COMPARATOR
Intervention: Control (current practices)
Number of subjects: 2806

Group type: EXPERIMENTAL
Intervention: e‐TIS app (high exposure)
Number of subjects: 2806
Study: 33949270

Group type: EXPERIMENTAL
Intervention: Stroke Coach
Number of subjects: 126

Group type: COMPARATOR
Intervention: Memory Training
Number of subjects: 126
Study: 34702767

Group type: EXPERIMENTAL
Intervention: Salbutamol vibrating-mesh nebulization through HFNC
Number of subjects: 15
Study: 33920626

Group type: EXPERIMENTAL
Intervention: Dietary liking and frequency of dietary behaviors
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Restrained eaters (low intakes of high fat/sweets)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Improvements in liking for a healthy diet
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Concurrent healthier diet liking and healthier intake
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Eating healthier but not healthier diet liking
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Change in liking and frequency of physical activity
Number of subjects: 58
Study: 32720870

Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV group; either monotherapy or with lomustine)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV group)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Non-BEV group (lomustine monotherapy)
Number of subjects: 254
Study: 33620021

Group type: EXPERIMENTAL
Intervention: Underwater treadmill gait training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Overground gait training
Number of subjects: 22
Study: 33957720

Group type: EXPERIMENTAL
Intervention: Blood group A
Number of subjects: 39850

Group type: COMPARATOR
Intervention: Blood group O
Number of subjects: 39850

Group type: EXPERIMENTAL
Intervention: Blood group B
Number of subjects: 39850

Group type: EXPERIMENTAL
Intervention: Blood group AB
Number of subjects: 39850

Group type: COMPARATOR
Intervention: Rh-negative
Number of subjects: 39850

Group type: EXPERIMENTAL
Intervention: Rh-positive
Number of subjects: 39850